학술논문

Mini-PE, a prime editor with compact Cas9 and truncated reverse transcriptase
Document Type
article
Source
Molecular Therapy: Nucleic Acids, Vol 33, Iss , Pp 890-897 (2023)
Subject
MT: RNA/DNA Editing
prime editor
miniature
CjCas9
truncated MMLV
AAV
Therapeutics. Pharmacology
RM1-950
Language
English
ISSN
2162-2531
Abstract
Prime editor (PE) is a versatile genome editing tool that does not need extra DNA donors or inducing double-strand breaks. However, in vivo implementation of PE remains a challenge because of its oversized composition. In this study, we screened out the smallest truncated Moloney murine leukemia virus (MMLV) reverse transcriptase (RT) with the F155Y mutation to keep gene editing efficiency. We discovered the most efficient gene editing variants of MMLV RT with the smallest size. After optimization of the pegRNAs and incorporation with nick sgRNAs, the mini-PE delivered up to 10% precise editing at target sites in human and mouse cells. It also edited the mouse Hsf1 gene in the mouse retina precisely after delivery with adeno-associated viruses (AAVs), although the editing efficiency was lower than 1%. We will focus on improving the editing efficiency of mini-PE and exploiting its therapeutic potential against human genetic diseases.